Cognition, psychosocial functioning, and health-related quality of life among childhood cancer survivors.


Journal

Neuropsychological rehabilitation
ISSN: 1464-0694
Titre abrégé: Neuropsychol Rehabil
Pays: England
ID NLM: 9112672

Informations de publication

Date de publication:
Jul 2022
Historique:
pubmed: 20 11 2020
medline: 11 9 2022
entrez: 19 11 2020
Statut: ppublish

Résumé

Long-term sequelae of cancer and its treatment render childhood cancer (CC) survivors vulnerable to cognitive and behavioural difficulties and likely affect their quality of life (QoL). Our aim was to compare levels of cognition, psychosocial functioning, and health-related QoL of CC survivors to healthy controls and examine the associations between these three domains. Seventy-eight CC survivors (age range = 7-16 years, ≥ one year since cancer treatment) and 56 healthy controls were included. Cognition (i.e., fluid intelligence, executive functions, memory, processing speed, and selective attention), psychosocial functioning, and health-related QoL were assessed using standardized tests and questionnaires. The cognitive performance, parent-reported psychosocial behaviour, and health-related QoL of the CC survivors were within the normative range. However, working memory was significantly poorer in survivors than controls, and visuospatial working memory below the normative range was more commonly observed among survivors than among controls. Processing speed significantly predicted survivors' performance in executive functions. Among survivors, greater peer problems were significantly associated with poorer cognitive functions and health-related QoL. Despite the evidence for good intellectual functioning, which might point towards adequate reserves, in some survivors, domain-specific difficulties may emerge years after cancer relating to psychosocial development and QoL.

Identifiants

pubmed: 33208044
doi: 10.1080/09602011.2020.1844243
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

922-945

Auteurs

Valerie Siegwart (V)

Division of Neuropediatrics, Development and Rehabilitation, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.
Department of Pediatric Hematology and Oncology, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Valentin Benzing (V)

Division of Neuropediatrics, Development and Rehabilitation, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.
Department of Pediatric Hematology and Oncology, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.
Institute of Sport Science, University of Bern, Bern, Switzerland.

Janine Spitzhuettl (J)

Division of Neuropediatrics, Development and Rehabilitation, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.
Department of Pediatric Hematology and Oncology, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.
Department of Psychology, University of Bern, Bern, Switzerland.

Mirko Schmidt (M)

Institute of Sport Science, University of Bern, Bern, Switzerland.

Michael Grotzer (M)

Department of Pediatric Oncology, University Children's Hospital Zurich, Zurich, Switzerland.

Maja Steinlin (M)

Division of Neuropediatrics, Development and Rehabilitation, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Kurt Leibundgut (K)

Department of Pediatric Hematology and Oncology, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Claudia Roebers (C)

Department of Psychology, University of Bern, Bern, Switzerland.

Regula Everts (R)

Division of Neuropediatrics, Development and Rehabilitation, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.
Department of Pediatric Hematology and Oncology, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH